dr. choueiri on the role of cabozantinib in rcc
Published 6 years ago • 222 plays • Length 0:52Download video MP4
Download video MP3
Similar videos
-
1:06
dr. choueiri on fda approval of cabozantinib for rcc
-
1:08
dr. choueiri on the biology of the cabosun trial for rcc
-
1:44
dr. choueiri on cabosun trial results in rcc
-
1:20
dr. choueiri on overall findings of cabosun trial for rcc
-
0:41
dr. toni choueiri on cabozantinib and nivolumab combination in kidney cancer
-
0:52
dr. choueiri on impact of cabosun results in renal cell carcinoma
-
1:45
dr. choueiri on cabosun trial results for rcc
-
1:35
dr. toni choueiri on cabozantinib versus everolimus in renal cell carcinoma
-
1:06
dr. toni choueiri on nivolumab and cabozantinib becoming first-line therapies in rcc
-
1:32
dr. mcgregor on the future of cabozantinib in rcc
-
1:47
dr. choueiri on the impact of the javelin renal 101 findings in rcc
-
2:17
dr. choueiri on the role of traditional agents in kidney cancer
-
1:33
dr. choueiri on the next generation of trials in rcc
-
1:14
dr. choueiri on significance of checkmate-025 study for rcc
-
0:29
dr. mckay on fda approval of frontline cabozantinib in rcc
-
1:52
dr. choueiri on using immunotherapy to treat rcc
-
2:46
dr. choueiri on results of the savoir trial in met-driven papillary rcc
-
1:02
dr. choueiri discusses the current state of rcc treatment
-
2:30
dr. choueiri on the subgroup analysis of the javelin renal 101 trial in rcc